<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Srivastava S</submitter><funding>department of biotechnology , ministry of science and technology</funding><pagination>104</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11071957</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>79(2)</volume><pubmed_abstract>Glioblastoma is the most life-threatening tumor of the central nervous system. Despite recent therapeutic advancements, maximum survival of glioblastoma patients remains dismal. The mediator complex is a set of proteins, essential for eukaryotic gene expression. Abnormal expression/mutations of specific mediator genes have been associated with progression of various cancers, however, its role and status in glioblastoma remains largely unknown. Our work shows overexpression of a subunit of kinase assembly of mediator complex, MED12, in various glioblastoma patient cohorts including Indian glioblastoma patients and cell lines. Functional characterization of MED12 using both overexpression and knockdown approach revealed that it promotes glioblastoma cell proliferation, migration and inhibits</pubmed_abstract><journal>Cellular and molecular life sciences : CMLS</journal><pubmed_title>MED12 is overexpressed in glioblastoma patients and serves as an oncogene by targeting the VDR/BCL6/p53 axis.</pubmed_title><pmcid>PMC11071957</pmcid><funding_grant_id>BT/PR16851/MED/122/45/2016</funding_grant_id><pubmed_authors>Srivastava S</pubmed_authors><pubmed_authors>Makala H</pubmed_authors><pubmed_authors>Sarkar C</pubmed_authors><pubmed_authors>Suri V</pubmed_authors><pubmed_authors>Kulshreshtha R</pubmed_authors><pubmed_authors>Sharma V</pubmed_authors></additional><is_claimable>false</is_claimable><name>MED12 is overexpressed in glioblastoma patients and serves as an oncogene by targeting the VDR/BCL6/p53 axis.</name><description>Glioblastoma is the most life-threatening tumor of the central nervous system. Despite recent therapeutic advancements, maximum survival of glioblastoma patients remains dismal. The mediator complex is a set of proteins, essential for eukaryotic gene expression. Abnormal expression/mutations of specific mediator genes have been associated with progression of various cancers, however, its role and status in glioblastoma remains largely unknown. Our work shows overexpression of a subunit of kinase assembly of mediator complex, MED12, in various glioblastoma patient cohorts including Indian glioblastoma patients and cell lines. Functional characterization of MED12 using both overexpression and knockdown approach revealed that it promotes glioblastoma cell proliferation, migration and inhibits</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2026-06-02T09:02:31.363Z</modification><creation>2026-04-16T03:13:15.329Z</creation></dates><accession>S-EPMC11071957</accession><cross_references><pubmed>35091793</pubmed><doi>10.1007/s00018-021-04056-6</doi></cross_references></HashMap>